Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 787195, 9 pages
http://dx.doi.org/10.1155/2014/787195
Research Article

Promoter Hypermethylation and Suppression of Glutathione Peroxidase 3 Are Associated with Inflammatory Breast Carcinogenesis

1Department of Zoology, Faculty of Science, Cairo University, Giza 12613, Egypt
2Department of Surgery, Vanderbilt University Medical Center, Nashville, TN 37232, USA
3Department of Pathology, National Cancer Institute, Cairo University, Giza 12613, Egypt
4Department of General Surgery, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt

Received 25 November 2013; Revised 22 January 2014; Accepted 30 January 2014; Published 20 March 2014

Academic Editor: Jeannette Vasquez-Vivar

Copyright © 2014 Mona M. Mohamed et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. J. Sipe Jr., S. J. Jordan, P. M. Hanna, and R. P. Mason, “The metabolism of 17β-estradiol lactoperoxidase: a possible source of oxidative stress in breast cancer,” Carcinogenesis, vol. 15, no. 11, pp. 2637–2643, 1994. View at Google Scholar · View at Scopus
  2. K. Plak, A. M. Czarnecka, T. Krawczyk, P. Golik, and E. Bartnik, “Breast cancer as a mitochondrial disorder (review),” Oncology Reports, vol. 21, no. 4, pp. 845–851, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Fulton and Y. C. Chong, “The role of macrophage-derived TNFa in the induction of sublethal tumor cell DNA damage,” Carcinogenesis, vol. 13, no. 1, pp. 77–81, 1992. View at Google Scholar · View at Scopus
  4. N. S. Brown and R. Bicknell, “Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer,” Breast Cancer Research, vol. 3, no. 5, pp. 323–327, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. D.-H. Kang, “Oxidative stress, DNA damage, and breast cancer,” AACN clinical issues, vol. 13, no. 4, pp. 540–549, 2002. View at Google Scholar · View at Scopus
  6. R. Brigelius-Flohé and A. Kipp, “Glutathione peroxidases in different stages of carcinogenesis,” Biochimica et Biophysica Acta, vol. 1790, no. 11, pp. 1555–1568, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. P. Rayman, “Selenium in cancer prevention: a review of the evidence and mechanism of action,” Proceedings of the Nutrition Society, vol. 64, no. 4, pp. 527–542, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. J.-Y. Wang, I.-P. Yang, D.-C. Wu, S.-W. Huang, J.-Y. Wu, and S.-H. H. Juo, “Functional glutathione peroxidase 3 polymorphisms associated with increased risk of Taiwanese patients with gastric cancer,” Clinica Chimica Acta, vol. 411, no. 19-20, pp. 1432–1436, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. Pawlowicz, B. A. Zachara, U. Trafikowska, A. Maciag, E. Marchaluk, and A. Nowicki, “Blood selenium concentrations and glutathione peroxidase activities in patients with breast cancer and with advanced gastrointestinal cancer,” Journal of Trace Elements and Electrolytes in Health and Disease, vol. 5, no. 4, pp. 275–277, 1991. View at Google Scholar · View at Scopus
  10. Y. P. Yu, G. Yu, G. Tseng et al., “Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis,” Cancer Research, vol. 67, no. 17, pp. 8043–8050, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Hasegawa, T. Takano, A. Miyauchi et al., “Decreased expression of glutathione peroxidase mRNA in thyroid anaplastic carcinoma,” Cancer Letters, vol. 182, no. 1, pp. 69–74, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. O.-J. Lee, R. Schneider-Stock, P. A. McChesney et al., “Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis,” Neoplasia, vol. 7, no. 9, pp. 854–861, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. He, Y. Wang, P. Li, S. Zhu, J. Wang, and S. Zhang, “Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma,” Digestive Diseases and Sciences, vol. 56, no. 3, pp. 681–688, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Chen, X. Rao, M. G. House, K. P. Nephew, K. J. Cullen, and Z. Guo, “GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy response,” Cancer Letters, vol. 309, no. 1, pp. 37–45, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Lodygin, A. Epanchintsev, A. Menssen, J. Diebold, and H. Hermeking, “Functional epigenomics identifies genes frequently silenced in prostate cancer,” Cancer Research, vol. 65, no. 10, pp. 4218–4227, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Falck, S. Karlsson, J. Carlsson, G. Helenius, M. Karlsson, and K. Klinga-Levan, “Loss of glutathione peroxidase 3 expression is correlated with epigenetic mechanisms in endometrial adenocarcinoma,” Cancer Cell International, vol. 10, article 46, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Zhang, J.-J. Yang, Y. S. Kim, K.-Y. Kim, W. S. Ahn, and S. Yang, “An 8-gene signature, including methylated and down-regulated glutathione peroxidase 3, of gastric cancer,” International Journal of Oncology, vol. 36, no. 2, pp. 405–414, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Qu, S. Dang, and P. Hou, “Gene methylation in gastric cancer,” Clinica Chimica Acta, vol. 424, pp. 53–65, 2013. View at Google Scholar
  19. M. F. Kaiser, D. C. Johnson, P. Wu et al., “Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma,” Blood, vol. 122, no. 2, pp. 219–226, 2013. View at Google Scholar
  20. D. F. Peng, T. L. Hu, B. G. Schneider, Z. Chen, Z. K. Xu, and W. El-Rifai, “Silencing of glutathione peroxidase 3 through DNA hypermethylation is associated with lymph node metastasis in gastric carcinomas,” PLoS ONE, vol. 7, no. 10, Article ID e46214, 2012. View at Google Scholar
  21. M. A. Nouh, M. M. Mohamed, M. El-Shinawi et al., “Cathepsin b: a potential prognostic marker for inflammatory breast cancer,” Journal of Translational Medicine, vol. 9, article 1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Bonnier, C. Charpin, C. Lejeune et al., “Inflammatory carcinomas of the breast: a clinical, pathological, or a clinical and pathological definition?” International Journal of Cancer, vol. 62, no. 4, pp. 382–385, 1995. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Gong, “Pathologic aspects of inflammatory breast cancer: part 2. Biologic insights into its aggressive phenotype,” Seminars in Oncology, vol. 35, no. 1, pp. 33–40, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. M. M. Mohamed, D. Al-Raawi, S. F. Sabet, and M. El-Shinawi, “Inflammatory breast cancer: new factors contribute to disease etiology (Review),” Journal of Advanced Research, 2013. View at Publisher · View at Google Scholar
  25. P. Storz, “Reactive oxygen species in tumor progression,” Frontiers in Bioscience, vol. 10, no. 2, pp. 1881–1896, 2005. View at Google Scholar · View at Scopus
  26. I.-C. Lo, J.-M. Shih, and M. J. Jiang, “Reactive oxygen species and ERK 1/2 mediate monocyte chemotactic protein-1-stimulated smooth muscle cell migration,” Journal of Biomedical Science, vol. 12, no. 2, pp. 377–388, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. W.-S. Wu, “The signaling mechanism of ROS in tumor progression,” Cancer and Metastasis Reviews, vol. 25, no. 4, pp. 695–705, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Genestie, B. Zafrani, B. Asselain et al., “Comparison of the prognostic value of Scarff-Bloom-Richardson and Nottingham histological grades in a series of 825 cases of breast cancer: major importance of the mitotic count as a component of both grading systems,” Anticancer Research, vol. 18, no. 1, pp. 571–576, 1998. View at Google Scholar · View at Scopus
  29. D. F. Peng, M. Razvi, H. Chen et al., “DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma,” Gut, vol. 58, no. 1, pp. 5–15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Christians, C. Hartmann, A. Benner et al., “Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma,” PLoS ONE, vol. 7, no. 3, Article ID e33449, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. J. Hu and A. M. Diamond, “Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium,” Cancer Research, vol. 63, no. 12, pp. 3347–3351, 2003. View at Google Scholar · View at Scopus
  32. P. Cejas, M. A. García-Cabezas, E. Casado et al., “Phospholipid Hydroperoxide Glutathione Peroxidase (PHGPx) expression is downregulated in poorly differentiated breast invasive ductal carcinoma,” Free Radical Research, vol. 41, no. 6, pp. 681–687, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. C. M. Woolston, A. Al-Attar, S. J. Storr, I. O. Ellis, D. A. L. Morgan, and S. G. Martin, “Redox protein expression predicts radiotherapeutic response in early-stage invasive breast cancer patients,” International Journal of Radiation Oncology Biology Physics, vol. 79, no. 5, pp. 1532–1540, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. C. B. Ambrosone, “Oxidants and antioxidants in breast cancer,” Antioxidants and Redox Signaling, vol. 2, no. 4, pp. 903–917, 2000. View at Google Scholar · View at Scopus
  35. S. Perwez Hussain, M. H. Hollstein, and C. C. Harris, “p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and human risk assessment,” Annals of the New York Academy of Sciences, vol. 919, pp. 79–85, 2000. View at Google Scholar · View at Scopus
  36. F. M. Robertson, M. Bondy, W. Yang et al., “Inflammatory breast cancer the disease, the biology, the treatment,” CA Cancer Journal for Clinicians, vol. 60, no. 6, pp. 351–375, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. M. M. Mohamed, E. A. El-Ghonaimy, M. A. Nouh, R. J. Schneider, B. F. Sloane, and M. El-Shinawi, “Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties,” The International Journal of Biochemistry & Cell Biology, vol. 46, pp. 138–147, 2014. View at Google Scholar
  38. C. W. Barrett, W. Ning, X. Chen et al., “Tumor suppressor function of the plasma glutathione peroxidase gpx3 in colitis-associated carcinoma,” Cancer Research, vol. 73, no. 3, pp. 1245–1255, 2013. View at Google Scholar